EFTA01743919Set 10
2015-07-231p96w
Biotechnologics (NASDAQ:AAVL) CEO Thomas Chalberg, Ph.D., resigns
effective today. The BOD appoints SVP of Business Operations Hans Hull as interim CEO
and President. A search for a permanent successor
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01743919.pdf